News & Events

Sandra Alfano, PharmD, research scientist (general internal medicine), Yale School of Medicine (YSM), and senior research analyst, Conflict of Interest Committee, Yale University, will retire in June.

Ira Leeds, MD, FACS, FASCRS, recently received an Association of VA Surgeons (AVAS) Faculty Research Award to study the relationship between housing instability and surgical outcomes using AI methods.

The majority of the estimated $206 billion resulting from the Tobacco Master Settlement Agreement have not gone to address smoking or public health. Following a similar settlement of a multi-state litigation, the state of Connecticut is expecting around $600 million to address the state’s opioid overdose crisis, which resulted in 1,340 overdose deaths in 2023 alone. To avoid the experience of the Tobacco funds, Yale faculty are proactively providing recommendations on how to spend these funds.

The newly announced election brings the number of AAP members from Yale to 53.

Most analyses regarding the excess risk of death during the COVID-19 pandemic have relied on summary data. However, a recent study published in the International Journal of Epidemiology instead analyzed individual patient-level data based on medical records from the largest integrated healthcare system in the United States.

Addiction treatment can mean anything from equine therapy to the peer-supported spiritual programming of 12-step recovery groups. Of the treatment options for opioid addiction, methadone and buprenorphine have the “strongest scientific evidence,” said Dr. David Fiellin, director of the Yale Program in Addiction Medicine.

According to the Centers for Disease Control and Prevention, cancer is a leading cause of death in the United States. Unfortunately for American men, prostate cancer remains one of the deadliest cancers. The Veterans Aging Cohort Study (VACS) Consortium sought to give physicians and other medical professionals guidance on how to determine treatment in patients with prostate cancer.

A study led by VA Connecticut Healthcare Center/Yale researchers reveals ancestries around the world possess a shared genetic architecture for problematic alcohol use – habitual heavy drinking, accompanied by harmful consequences. Hang Zhou, PhD, assistant professor of psychiatry and of biomedical informatics & data science at Yale School of Medicine and VA Connecticut, and Joel Gelernter, MD, Foundations Fund Professor of Psychiatry, and professor of genetics and of neuroscience at Yale School of Medicine and VA Connecticut, were first and senior authors, respectively.